Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-31T15:31:06.457Z Has data issue: false hasContentIssue false
  • English
  • Français

Plasma soluble interleukin-2-receptor in depression: relationships to plasma neopterin and serum IL-2 concentrations and HPA-axis activity

Published online by Cambridge University Press:  16 April 2020

M Maes ,
E Bosmans ,
S Scharpé ,
P D'Hondt  and
R Desnyder
M Maes
Affiliation:
University Department of Psychiatry, AZ Stuivenberg, 267 Lange Beeldekensstraat, 2060Antwerp, Belgium Departments of Psychiatry, University Hospitals of Antwerp, Antwerp, Belgium Cleveland, Ohio, USA
E Bosmans
Affiliation:
Eurogenetics, Tessenderlo, Belgium
S Scharpé
Affiliation:
Department of Medical Biochemistry, University of Antwerp, Wilrijk, Belgium
P D'Hondt
Affiliation:
Departments of Psychiatry, University Hospitals of Antwerp, Antwerp, Belgium
R Desnyder
Affiliation:
University Department of Psychiatry, AZ Stuivenberg, 267 Lange Beeldekensstraat, 2060Antwerp, Belgium
Get access

Summary

The present study examined the plasma concentration of the soluble interleukin-2-receptor (sIL-2R) in depressed subjects in relation to hypothalamic pituitary adrenal (HPA) axis function and plasma neopterin and serum IL-2 concentrations. Plasma sIL-2R concentration was significantly higher in depressed patients (n = 47) than in controls (n = 19). There were no significant correlations between plasma sIL-2R and severity of illness. In the depressed subjects, there was a highly significant relationship between plasma sIL-2R and neopterin concentrations. Depressed patients with pathologically increased plasma neopterin levels had significantly higher plasma sIL-2R values than those with normal serum neopterin. There were no significant relationships between plasma sIL-2R and indices of HPA-axis function in depression. There was no significant effect of dexamethasone administration on sIL-2R levels. Significantly more depressed subjects had measurable serum IL-2 levels than normal controls. Our data support the notion that a moderate activation of cell-mediated immunity may play a role in the pathophysiology of depression.

Keywords

soluble interleukin-2 receptorneopterindepressionhypothalamic-pituitary-adrenal-axiscortisolimmune disorders
Type
Original article
Information
European Psychiatry , Volume 10 , Issue 8 , 1995 , pp. 397 - 403
Copyright
Copyright © Elsevier, Paris 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association third edition, revised Diagnostic and Statistical Manual of Mental Disorders Washington, DC: American Psychiatric Association, 1987Google Scholar
Arya, SKWong-Staal, FGallo, RCDexamethasone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. J Immunol 1984; 133: 273–6Google Scholar
Bogner, MPVoss, SDBechhofer, R, et al.Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression. J Immunotherapy 1992; 11: 111–118CrossRefGoogle ScholarPubMed
Boumpas, DTAnastassiou, EDOlder, SATsokos, GCNelson, DLBalow, JEDexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J Clin Invest 1991; 87: 1739–47CrossRefGoogle Scholar
Caruso, CCandore, GCigna, DColucci, ATModica, MABiological significance of soluble IL-2 receptor Med Inflamm 1993; 2: 3–21Google ScholarPubMed
Duch, DSWoolf, JHNichol, CADavidson, JRGarbutt, JCUrinary excretion of biopterin and neopterin in psychiatric disorders. Psychiatry Res 1984; 11: 83–89CrossRefGoogle ScholarPubMed
Dunbar, PRHill, JNeale, TJMellsop, GWNeopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychol Med 1992; 22: 1051–57CrossRefGoogle Scholar
Fuchs, DWeiss, GReibnegger, GWachter, HThe role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 1992; 29: 307–41CrossRefGoogle ScholarPubMed
Gillis, SCrabtree, GRSmith, KAGlucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 1979; 123: 1624–38Google ScholarPubMed
Hamilton, MA rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62CrossRefGoogle ScholarPubMed
Hickie, IHickie, CLloyd, ASilove, DWakefield, DImpaired in vivo immune responses in patients with melancholia. Br J Psychiatry 1993; 162: 651–7CrossRefGoogle ScholarPubMed
Howell, DCMultiple comparisons among treatment means., In: Howell, DCStatistical Methods for Psychology Boston: Duxbury Press, 1982 289–307Google Scholar
Huber, CBatchelor, JR, et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon gamma. J Exp Med 1984; 160: 310–16CrossRefGoogle ScholarPubMed
Lamas, MSanz, EMartin-Parras, L, et al. Glucocorticoid hormones upregulate interleukin 2 receptor a gene expression. Cell Immunol 1993; 151: 437–50Google Scholar
Maes, M Evidence for an immune response in major depression: a review and hypothesis. Progr Neuropsychopharmacol Biol Psychiatry 1995in pressCrossRefGoogle Scholar
Maes, MBosnians, ESuy, EMinner, BRaus, JThe impaired mitogen lymphocyte stimulation in severely depressed patients: a complex interface between HPA-axis hyperfunction, noradrenergic activity and the ageing process. Br J Psychiatry 1989; 155: 793–8CrossRefGoogle ScholarPubMed
Maes, MBosnians, ESuy, EVandervorst, CDejonckheere, CMinner, BRaus, JDepression-related disturbances in mitogen-induced lymphocyte responses, interleukin-β, and soluble interleukin-2-receptor production. Acta Psychiatr Scand 1991a; 84: 379–86CrossRefGoogle Scholar
Maes, MBosnians, ESuy, EVandervorst, CDejonckheere, CRaus, JAntiphospholipid, anti-nuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients. J Affective Disord 1991b; 21: 133–40CrossRefGoogle Scholar
Maes, MVandervorst, CSuy, EMinner, BRaus, JA multivariate study on the simultaneous urinary free cortisol, plasma Cortisol, adrenocorticotropic hormone β-endorphin escape from suppression by dexamethasone in melancholic patients. Acta Psychiatr Scand 1991c; 83: 480–91CrossRefGoogle Scholar
Maes, MLambrechts, JBosmans, E, et al. Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 1992; 22: 45–53CrossRefGoogle ScholarPubMed
Maes, MMeltzer, HYStevens, WCosyns, PBlockx, PMultiple and reciprocal relationships between in vivo cellular immunity and hypothalamic-pituitary-adrenal-axis in depression. Psychol Med 1994a; 24: 167–177CrossRefGoogle ScholarPubMed
Maes, MScharpé, SMeltzer, HY, et al. Increased neopterin and Interferon γ secretion and lower availability of L-tryptophan in major depression: further evidence for activation of cell-mediated immunity. Psychiatry Res 1994b; 20: 111–16Google Scholar
Maes, MSmith, RScharpé, SThe monocyte-T lymphocyte hypothesis of major depression. Psychoneuroendocrinol 1995; 20: 111–16CrossRefGoogle ScholarPubMed
Maes, MStevens, WDeClerck, L, et al. A significantly increased expression of T cell activation markers in depression: additional evidence for an inflammatory process during that illness. Progr Psychopharmacol Biol Psychiatry 1993; 17: 241–55Google Scholar
Nassberger, LTraskman-Bendz, LIncreased soluble interleukin-2 receptor concentrations in suicide attempters. Acta Psychiatr Scand 1993; 88: 48–52CrossRefGoogle ScholarPubMed
Plata-Salaman, CRImmunoregulators in the nervous system. Neurosci Biobehav Rev 1991; 15: 185–215CrossRefGoogle ScholarPubMed
Reed, JCAbidi, AHAlpers, JDHoover, RGRobb, RJNowell, PCEffect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. J Immunol 1986; 37: 150–154Google Scholar
Sauer, JRupprecht, MArzt, EStalla, GKRupprecht, RGlueocorticoids modulate soluble interleukin-2 receptor levels in vivo depending on the state of immune activation and the duration of glucocorticoid exposure. Immunopharmacology 1993; 25: 269–276CrossRefGoogle ScholarPubMed
Spitzer, RLWilliams, JBWGibbon, MSWFirst, MBStructured Clinical Interview according to DSM-III-R New York: American Psychiatric Press, Inc, 1990Google Scholar
Wachter, HFuchs, DHausen, A, et al. Neopterin; Biochemistry, Methods, and Clinical Application Berlin, New York: Walter de Gruyter, 1992CrossRefGoogle Scholar
Werner, ERBichler, ADaxenbichler, G, et al. Determination of neopterin in serum and urine. Clin Chem 1987; 33: 62–6CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.